ArticleHereditas2025
Effect of Wendan decoction granules on preventing endolymphatic hydrops and protecting vestibular function in Guinea pigs.
Article in Hereditas, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
objectiveThe aim of this study is to assess the therapeutic effects of Wendan decoction on endolymphatic hydrops (EH), a condition characterized by excessive inner ear fluid accumulation that is associated with Meniere's disease, in guinea pigs, offering insights for clinical application.
methodsThe active components and action targets of compound Wendan decoction were identified using BATMAN-TCM in this study. Gene Ontology (GO) analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis were conducted on Metascape and bioinformatics.com.cn platforms. Cytoscape was used to construct the TCM-compound-target-disease network and the disease-target pathway network for visual representation. The chemical profile of Wendan decoction was characterized through UHPLC-QTOF/MS. Guinea pigs were used to establish an EH model. The effects of Wendan decoction granules on neurological function, cochlear hydrops, the ultrastructure of the cochlear Corti organ area, inflammatory response, and the expression of AQP2 and P38MAPK in guinea pigs were examined using behavioral experiments, hematoxylin and eosin staining, scanning electron microscopy, ELISA, qRT-PCR, and immunohistochemistry staining.
resultsA total of 103 components, primarily flavonoids and triterpenoid saponins, were identified in Wendan decoction. Wendan decoction significantly inhibited the MAPK signaling pathway. Wendan decoction granules alleviated neurological impairment induced by EH. Following treatment, guinea pigs exhibited reduced membranous labyrinth hydrops and decreased outer hair cell loss. Wendan decoction granules also suppressed the release of pro-inflammatory factors and reduced AQP2 protein expression in model guinea pigs.
conclusionWendan decoction granules effectively alleviated neurological impairment and inflammatory responses, preserved cochlear structure, reduced inflammation, and modulated AQP2 expression, offering a strong basis for further investigation of its therapeutic potential.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.